Frontiers | Emerging Molecules in Pulmonary Hypertension: Diagnosis, Risk Prediction, Treatment and Prognosis

Emerging Molecules in Pulmonary Hypertension: Diagnosis, Risk Prediction, Treatment and Prognosis

411
Total downloads
2,917
Total views and downloads

Articles

CASE REPORT

Accepted on 23 Jan 2025

Dangerous Liaisons between Splenectomy and Eltrombopag-Induced Chronic Thromboembolic Pulmonary Hypertension in Patients with Immune Thrombocytopenia: Report of Two Cases and Review of the Literature

Roberto Castelli
Enrico Atzori
Alessandro Palmerio Delitala
Salvatore Antonio Masala
Valentina Micheluzzi
Enrico Ponti
Giuseppe Sanna
Dante Castro
Antonio Gidaro
4 more
Gavino Casu

doi 10.3389/fcvm.2025.1508574

ORIGINAL RESEARCH

Published on 18 Nov 2024

A combination of clinical, electrocardiographic, and echocardiographic parameters predicts pulmonary hypertension occurrence in patients with end-stage renal disease

Handong Ding
Fei Zhang
Jinbiao Zhong
Jiashan Pan
Yiding Chen
Ji Zhang
Qin Wang
Guiyi Liao
Zongyao Hao

A combination of clinical, electrocardiographic, and echocardiographic parameters predicts pulmonary hypertension occurrence in patients with end-stage renal disease

doi 10.3389/fcvm.2024.1337243

276 views

ORIGINAL RESEARCH

Published on 15 Oct 2024

Investigating the causal relationship between human blood metabolites and pulmonary hypertension: a two-sample Mendelian randomization study

Xingdu Zeng
Bin Zhong

Investigating the causal relationship between human blood metabolites and pulmonary hypertension: a two-sample Mendelian randomization study

doi 10.3389/fcvm.2024.1304986

945 views

Share on

Frontiers in Cardiovascular Medicine

Frontiers in Cardiovascular Medicine

Hypertension

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

2,917Topic views
1,179Article views
411Article downloads